On today’s STOP TRADING segment on CNBC, Jim Cramer covered a few issues.
He noted Pfizer (PFE) again, saying it was another Bristol-Myers (BMY). He said it is a $25.00 bond now, that has almost no upside. Regarding the safety board, he said them not even knowing of a possibility of issues.
Going hunting, Cramer said Cabellas (CAB) is one that is winning from hunting trends again. He said the analysts also refuse to upgrade it and they might be wrong.
Cramer thinks Archer-Daniels (ADM) is a winner trading cheap.
Jon C. Ogg
December 4, 2006